Updated prescribing information

Following a review by the Commission on Human Medicines (CHM), updated advice on the prescribing and dispensing of oral tacrolimus products has been agreed. This updated advice is that all oral tacrolimus medicines in the UK should be prescribed and dispensed by brand name only.

Further information:

MHRA press release

Letter sent to healthcare professionals

Questions and answers document